<h2 id="mechanism-of-action">Mechanism of Action</h2>
<h2 id="pharmacology">Pharmacology</h2>
<p>Half life is 40 hours</p>
<h2 id="indications">Indications</h2>
<p>[[Post-operative Nausea and Vomiting]]</p>
<ul>
  <li>reduces incidence of POV (not nausea)</li>
  <li>More efficacious than [[Ondansetron]]<sup id="fnref:1" role="doc-noteref"><a href="#fn:1" class="footnote" rel="footnote">1</a></sup></li>
  <li>Useful as a <em>prophylactic anti-emetic</em>
    <h2 id="dosage">Dosage</h2>
    <p>40, 80, 125 mg PO are all effective</p>
    <h2 id="complications">Complications</h2>
  </li>
</ul>
<h2 id="references">References</h2>
<div class="footnotes" role="doc-endnotes">
  <ol>
    <li id="fn:1" role="doc-endnote">
      <p>[[Tong J. Gan, Kumar G. Belani, Sergio Bergese, Frances Chung, Pierre Diemunsch, Ashraf S. Habib, Zhaosheng Jin, Anthony L. Kovac, Tricia A. Meyer, Richard D. Urman, Christian C. Apfel, Sabry Ayad, Linda Beagley, Keith Candiotti, Marina Englesakis, Traci L. Hedrick, Peter Kranke, Samuel Lee, Daniel Lipman, Harold S. Minkowitz, John Morton, Beverly K. Philip, Fourth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting, 2020]]Â <a href="#fnref:1" class="reversefootnote" role="doc-backlink">&#8617;</a></p>
    </li>
  </ol>
</div>